SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo
By K. P. Hui, J. Ho, Man-chun Cheung, Ka-chun Ng, R. Ching, Ka-ling Lai, T. Kam, H. Gu, Ko-Yung Sit, M. Hsin and 5 more. Nature, 2022
712 citations recorded by the source corpus.
Subfields: Infectious Diseases
View Paper: https://www.semanticscholar.org/paper/ec8168d913b0f3dbbfe10c5d047a94aeeae922a5
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- S. Nash
- J. L. Bernal
- W. Hinsley
- K. Harman
- A. Zaidi
- T. Nyberg
- H. Webster
- N. A. Aziz
Citations in the corpus
- Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study (2022, positive): “30,31 Children with omicron infection may, therefore, be more likely than those with delta infection to present with fever and upper respiratory symptoms that would trigger clinical pathways for admission, for example to rule out sepsis.”